Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology Share Issue/Capital Change 2020

Sep 21, 2020

3535_rns_2020-09-21_4785fba4-78eb-40b2-8df7-736f2fc2dc5d.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

AQUA BIO TECHNOLOGY ASA - REGISTRATION OF SHARE CAPITAL INCREASE

AQUA BIO TECHNOLOGY ASA - REGISTRATION OF SHARE CAPITAL INCREASE

Reference is made to the stock exchange notice of Aqua Bio Technology ASA (the

"Company") dated 18 August 2020 regarding completion of two private placements

and to a stock exchange notice dated 11 September 2020 regarding completion of a

subsequent offering.

Through these share capital increases the share capital of the Company has been

increased with NOK 7,578,000 through issuance of 3,031,200 new shares, each with

a par value of NOK 2.50.

The share capital increases pertaining to the above share issues has now been

registered in the Norwegian Register of Business Enterprises. The new share

capital of the Company is NOK 45,998,427.50 divided by 18,399,371 shares, each

with a par value of NOK 2.50. The new shares will be admitted to trading on Oslo

Axess as soon as possible under ticker "ABT".

For further information, please contact Espen Kvale, acting CEO, telephone

+47 916 28 092 or [email protected]

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. Aqua Bio Technology is listed on the Axess market of the

Oslo Stock Exchange.

This information is subject to the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act.